DI Markus Roucka

Markus initiated his career in the biotechnical laboratories of Biomin GmbH, Austria as Lab technician in the R&D department. He was responsible for manufacturing and QC processes of the products. After almost 5 years he decided to attend University of Applied Science to study “Medical and Pharmaceutical Biotechnology” at the IMC Krems, Austria. For his Master thesis Markus went to The Netherlands and studied the effect of the TRIAL-ligand in combination with Bortezomib on NSCLC. After that he changed from green to the red biotechnology and started his career at VelaLabs in 2008 as Senior technician in the QC department, responsible for qualification and validation of assays for large molecules. Afterwards he was 8 years Head of Laboratory installing Projects and QC processes and afterwards two years Chief Operating Officer (COO). After the foundation of a Business Development Group within VelaLabs and increased further business, he became Managing Director of VelaLabs in Vienna between 2019-2023 thereby managing up to 95 employees. His current position now in the Tentamus Group as Head Business Development responsible for further strategic decisions within the Tentamus Pharma Group.